C. O. Ecevit Et Al. , "Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients," PEDIATRIC BLOOD & CANCER , vol.63, 2016
Ecevit, C. O. Et Al. 2016. Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients. PEDIATRIC BLOOD & CANCER , vol.63 .
Ecevit, C. O., Aktas, S., Yildirim, H. T., Demirag, B., Erbay, A., Karaca, I., ... Celik, A.(2016). Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients. PEDIATRIC BLOOD & CANCER , vol.63.
Ecevit, C. Et Al. "Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients," PEDIATRIC BLOOD & CANCER , vol.63, 2016
Ecevit, C. O. Et Al. "Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients." PEDIATRIC BLOOD & CANCER , vol.63, 2016
Ecevit, C. O. Et Al. (2016) . "Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients." PEDIATRIC BLOOD & CANCER , vol.63.
@article{article, author={C. O. Ecevit Et Al. }, title={Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients}, journal={PEDIATRIC BLOOD & CANCER}, year=2016}